← Leaderboards
Timothy A Roehrs
Henry Ford Health System
$9,090,809
Attributed
$11,101,670
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$11,101,670 · 6
By mechanism
R01$7,079,947 · 5
U01$4,021,723 · 1
Top collaborators
- Mark K. Greenwald1 shared
Most similar at Henry Ford Health System
Same institution · by research overlap
- Christopher L Drake$7,457,065
- Gary Steven Richardson$1,608,750
Others in their field
Top investigators on “Sleep”
- Chanza Baytop · Westat, Inc.$271,217,917
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Stanley Carlton Ahalt · Univ Of North Carolina Chapel Hill$78,409,067
- Michael W Weiner · Northern California Institute Res &Educ$71,598,372
- Susan S Redline · Brigham And Women'S Hospital$70,983,879
- Richard Gibbs · Baylor College Of Medicine$68,573,551
Research focus
SleepClinical ResearchHuman SubjectSelf MedicationSedative /HypnoticPolysomnographyPharmaceutical PreparationsReinforcerDoseSleeplessnessBenzodiazepine ReceptorCatecholaminesDesignPharmacological TreatmentSelf AdministrationMoodsHypnoticSleep DisordersDependenceBehavioralAlcoholism /Alcohol AbuseLigandsChronicUrinary
Grant awards (20)
Dual-orexin antagonism as a mechanism for improving sleep and drug abstinence in opioid use disorder$4,021,723
U01 · FY2019 · HL
Risks for Transition from Therapeutic Hypnotic Use to Abuse$536,372
R01 · FY2019 · DA · contact PI
Risks for Transition from Therapeutic Hypnotic Use to Abuse$548,400
R01 · FY2018 · DA · contact PI
Risks for Transition from Therapeutic Hypnotic Use to Abuse$548,400
R01 · FY2017 · DA · contact PI
Risks for Transition from Therapeutic Hypnotic Use to Abuse$542,916
R01 · FY2016 · DA · contact PI
Risks for Transition from Therapeutic Hypnotic Use to Abuse$562,773
R01 · FY2015 · DA · contact PI
Abuse Liability Associated with Chronic Hypnotic Use$367,949
R01 · FY2008 · DA · contact PI
Abuse Liability Associated with Chronic Hypnotic Use$364,992
R01 · FY2007 · DA · contact PI
Abuse Liability Associated with Chronic Hypnotic Use$365,066
R01 · FY2006 · DA · contact PI
Abuse Liability Associated with Chronic Hypnotic Use$363,090
R01 · FY2005 · DA
Insomnia as a Path to Alcohol Abuse$321,750
R01 · FY2005 · AA
Abuse Liability Associated with Chronic Hypnotic Use$351,334
R01 · FY2004 · DA
Insomnia as a Path to Alcohol Abuse$321,750
R01 · FY2004 · AA
Insomnia as a Path to Alcohol Abuse$321,750
R01 · FY2003 · AA
Insomnia as a Path to Alcohol Abuse$313,268
R01 · FY2002 · AA
SLEEPINESS AND THE REINFORCING EFFECT OF METHYLPHENIDATE$276,206
R01 · FY2002 · DA
Insomnia as a Path to Alcohol Abuse$313,268
R01 · FY2001 · AA
SLEEPINESS AND THE REINFORCING EFFECT OF METHYLPHENIDATE$268,163
R01 · FY2001 · DA
SLEEPINESS AND THE REINFORCING EFFECT OF METHYLPHENIDATE$260,350
R01 · FY2000 · DA
ABUSE LIABILITY OF ETHANOL AS A HYNOTIC BY INSOMNIACS$132,150
R01 · FY2000 · AA